ArticleJournal of cancer research and clinical oncology2025

Real-world evidence on the additional cancer risk reduction of ezetimibe: a 10-year nationwide retrospective cohort study emulating a target trial.

Yohwan Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.